Health outcomes of electronic cigarettes

• Published in: Chinese medical journal Vol. 137; no. 16; pp. 1903 - 1911
• Main Authors: Li, Xinmeng, Yuan, Lingzhi, Wang, Fen
• Format: Journal Article
• Language: English
• Published: Baltimore Lippincott Williams & Wilkins Ovid Technologies 20.08.2024; Lippincott Williams & Wilkins; Wolters Kluwer
• Subjects: Chronic obstructive pulmonary disease; Clinical outcomes; Coronaviruses; COVID-19; Electronic cigarettes; Inflammatory bowel disease; Metabolic disorders; Review
• ISSN: 0366-6999; 2542-5641; 2542-5641
• DOI: 10.1097/CM9.0000000000003098

Abstract The usage of electronic cigarettes (e-cigarettes) sparked an outbreak of unidentified vaping-related lung disease in the US during late 2019. With e-cigarettes becoming more and more popular, smokers have more options other than conventional cigarettes. Under these circumstances, a comprehensive evaluation of the general safety of new tobacco and tobacco-related products, represented by e-cigarettes, to human health is necessary. In this review, we summarize the current research on potential negative impacts of e-cigarette exposure on human health. In particular, studies detailing the relationship between e-cigarettes and the digestive system are summarized, with mechanisms mainly including hepatic metabolic dysfunction, impaired gut barrier, and worsened outcomes of inflammatory bowel disease (IBD). Although believed to be safer than traditional cigarettes, e-cigarettes exert adverse effects on systemic health and induce the development of multiple diseases including asthma, cardiovascular disease, and IBD. Moreover, nicotine-containing e-cigarettes have a negative impact on the childhood development and increase the risk of arterial stiffness compared to the non-nicotine e-cigarettes. However, non-nicotine e-cigarette components have detrimental effects including promoting liver damage and metabolic disorders.